Granulocyte-colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia
Open Access
- 11 November 2004
- Vol. 103 (1), 210
- https://doi.org/10.1002/cncr.20742
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Granulocyte–colony‐stimulating factor (filgrastim) may overcome imatinib‐induced neutropenia in patients with chronic‐phase chronic myelogenous leukemiaCancer, 2004
- Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid LeukemiaNew England Journal of Medicine, 2003
- Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitroBlood, 2002
- During ontogeny primitive (CD34+CD38−) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterpartsBlood, 2000
- Differentiation and proliferation of hematopoietic stem cellsBlood, 1993